| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |